Di-(2-ethylhexyl) phthalate upregulates ATF3 expression and suppresses apoptosis in mouse genital tubercle

Journal of Occupational Health

Volumn 51, Issue 1, 2009, Pages 57-63

  Liu, Xing ^a   Zhang, De Ying ^a   Li, Ya Sha ^b   Xiong, Jing ^a   He, Da Wei ^a   Lin, Tao ^a   Li, Xu Liang ^a   Wei, Guang Hui ^a  

^a Chongqing Children's Hospital   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Activating transcription factor 3; Apoptosis; Di (2 ethylhexyl) phthalate; Hypospadias; Mouse

Indexed keywords

MUS; ZEA MAYS;

ACTIVATING TRANSCRIPTION FACTOR 3; ATF3 PROTEIN, MOUSE; CORN OIL; MESSENGER RNA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLASTICIZER; PROTEIN BAX;

ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; HYPOSPADIAS; MALE; MALE GENITAL SYSTEM; MOUSE; PREGNANCY; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CORN OIL; DIETHYLHEXYL PHTHALATE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, BCL-2; GENES, P53; GENITALIA, MALE; HYPOSPADIAS; MALE; MICE; MICE, INBRED C57BL; PLASTICIZERS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 65549157630     PISSN: 13419145     EISSN: 13489585     Source Type: Journal    
DOI: 10.1539/joh.L8091     Document Type: Article

References (31)

1. Huber WW, Grasl-Kraupp B, Schulte-Hermann R. Hepatocarcinogenic potential of di(2-ethylhexyl) phthalate in rodents and its implications on human risk. Crit Rev Toxicol 1996; 26: 365-481.
2. Barlow NJ, Foster PM. Pathogenesis of male reproductive tract lesions from gestation through adulthood following in utero exposure to Di(n-butyl) phthalate. Toxicol Pathol 2003; 31: 397-410.
3. Koch HM, Preuss R, Angerer J. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-an update and latest results. Int J Androl 2006; 29: 155-65.
4. Shea KM. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics 2003; 111: 1467-74.
5. Song XF, Wei GH, Liu X, Zhang DY, Chen X, Deng YJ. Effects of diethylhexyl phthalate (DEHP) on INSL3 mRNA expression by Leydig cells derived from mouse embryos and in newborn mice. J Int Med Res 2008; 36: 512-21.
6. Liu X, He DW, Zhang DY, Lin T, Wei GH. Di(2-Ethylhexyl) phthalate (DEHP) increases transforming growth factor-β1 expression in fetal mouse genital tubercles. J Toxicol Environ Health, Part A 2008; 71: 1289-94.
7. Hai T, Hartman MG. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001; 273: 1-11.
8. Inoue A, Yoshida N, Omoto Y, et al. Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 2002; 29: 175-92.
9. Pan Y, Chen H, Siu F, Kilberg MS. Amino acid deprivation and endoplasmic reticulum stress induce expression of multiple activating transcription factor- 3 mRNA species that when overexpressed in HepG2 cells, modulate transcription by the human asparagine synthetase promoter. J Biol Chem 2003; 278: 38402-12.
10. Beleza-Meireles A, Töhönen V, Söderhäll C, et al. Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias. Eur J Endocrinol 2008; 158: 729-39.
11. Liu B, Wang Z, Lin G, et al. Activating transcription factor 3 is up-regulated in patients with hypospadias. Pediatr Res 2005; 58: 1280-3.
12. Liu B, Agras K, Willingham E, Vilela ML, Baskin LS. Activating transcription factor 3 is estrogen-responsive in utero and upregulated during sexual differentiation. Horm Res 2006; 65: 217-22.
13. Liu B, Lin G, Willingham E, et al. Estradiol upregulates activating transcription factor 3, a candidate gene in the etiology of hypospadias. Pediatr Dev Pathol 2007; 10: 446-54.
14. Willingham E, Baskin LS. Candidate genes and their response to environmental agents in the etiology of hypospadias. Nat Clin Pract Urol 2007; 4: 270-9.
15. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 1995; 103: 113-22.
16. Harris CA, Henttu P, Parker MG, Sumpter JP. The estrogenic activity of phthalate esters in vitro. Environ Health Perspect 1997; 105: 802-11.
17. van der Werff JF, Nievelstein RA, Brands E, Luijsterburg AJ, Vermeij-Keers C. Normal development of the male anterior urethra. Teratology 2000; 61: 172-83.
18. Kim IY, Han SY, Moon A. Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells. J Toxicol Environ Health, Part A 2004; 67: 2025-35.
19. Maire MA, Rast C, Vasseur P. Di-(2-ethylhexyl)phthalate (DEHP) increases Bcl-2/Bax ratio and modifies c-myc expression in Syrian hamster embryo (SHE) cells. Toxicol Lett 2005; 158: 237-45.
20. Kang KS, Lee YS, Kim HS, Kim SH. DI-(2-ethylhexyl) phthalate-induced cell proliferation is involved in the inhibition of gap junctional intercellular communication and blockage of apoptosis in mouse Sertoli cells. J Toxicol Environ Health, Part A 2002; 65: 447-59.
21. Gray LE Jr, Wolf C, Lambright C, et al. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 1999; 15: 94-118.
22. Mylchreest E, Sar M, Cattley RC, Foster PM. Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicol Appl Pharmacol 1999; 156: 81-95.
23. Baskin LS, Himes K, Colborn T. Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect 2001; 109: 1175-83.
24. Morgan EA, Nguyen SB, Scott V, Stadler HS. Loss of Bmp7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia. Development 2003; 130: 3095-109.
25. Suzuki K, Bachiller D, Chen YP, et al. Regulation of outgrowth and apoptosis for the terminal appendage: external genitalia development by concerted actions of BMP signaling. Development 2003; 130: 6209-20.
26. Francis JS, Dragunow M, During MJ. Over expression of ATF-3 protects rat hippocampal neurons from in vivo injection of kainic acid. Brain Res Mol Brain Res 2004; 124: 199-203.
27. Zhang J, Zhang D, McQuade JL, Behbehani M, Tsien JZ, Xu M. c-fos regulates neuronal excitability and survival. Nat Genet 2002; 30: 416-20.
28. Nobori K, Ito H, Tamamori-Adachi M, et al. ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3. J Mol Cell Cardiol 2002; 34: 1387-97.
29. Yan C, Wang H, Boyd DD. ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent transactivation of the collagenase promoter. J Biol Chem 2002; 277: 10804-12.
30. Kawauchi J, Zhang C, Nobori K, et al. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem 2002; 277: 39025-34.
31. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.